KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 13 filers reported holding KAZIA THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,939 | -1.5% | 6,353 | +64.7% | 0.00% | – |
| Q3 2022 | $4,000 | -60.0% | 3,857 | +56.2% | 0.00% | – |
| Q2 2022 | $10,000 | -61.5% | 2,470 | -19.0% | 0.00% | – |
| Q4 2021 | $26,000 | +420.0% | 3,050 | +653.1% | 0.00% | – |
| Q3 2021 | $5,000 | -75.0% | 405 | -74.9% | 0.00% | – |
| Q1 2021 | $20,000 | -20.0% | 1,616 | -43.3% | 0.00% | – |
| Q4 2020 | $25,000 | +177.8% | 2,851 | +115.8% | 0.00% | – |
| Q3 2020 | $9,000 | – | 1,321 | +1221.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 100 | -98.8% | 0.00% | – |
| Q1 2020 | $25,000 | +316.7% | 8,659 | +467.4% | 0.00% | – |
| Q4 2019 | $6,000 | – | 1,526 | +1426.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 100 | -86.9% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 766 | -50.5% | 0.00% | – |
| Q1 2019 | $5,000 | -44.4% | 1,546 | -61.3% | 0.00% | – |
| Q4 2018 | $9,000 | -55.0% | 3,994 | -34.1% | 0.00% | – |
| Q3 2018 | $20,000 | +5.3% | 6,059 | -6.0% | 0.00% | – |
| Q2 2018 | $19,000 | +280.0% | 6,443 | +571.1% | 0.00% | – |
| Q1 2018 | $5,000 | -50.0% | 960 | -68.6% | 0.00% | – |
| Q4 2017 | $10,000 | – | 3,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 99,180 | $857,000 | 0.09% |
| HighPoint Advisor Group LLC | 32,435 | $368,000 | 0.04% |
| Transform Wealth, LLC | 106,245 | $95,000 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 19,600 | $170,000 | 0.00% |
| Renaissance Technologies | 79,625 | $688,000 | 0.00% |
| TRUIST FINANCIAL CORP | 35,260 | $304,000 | 0.00% |
| UBS Group AG | 2,851 | $25,000 | 0.00% |
| BREWIN DOLPHIN LTD | 32 | $276 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,800 | $24,000 | 0.00% |